We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRSA Rapidly Detected in Mixed Samples

By HospiMedica staff writers
Posted on 20 Dec 2006
A new kit rapidly detects methicillin-resistant Staphylococcus aureus (MRSA) even in cases of mixed colonization.

The GenoQuick MRSA kit utilizes MRSA-specific DNA sequences in the Staphylococcal cassette chromosome (SSCmec types 1-V) to enable direct testing without the need for time-consuming culture. More...
A simple dipstick procedure accelerates the detection process with results being generated as an obvious banding pattern on the membrane strips. The presence of both amplification and conjugate controls gives the user confidence in reporting the presence of MRSA from a patient specimen to a sensitivity of 10-15 colony forming units (cfu). No elaborate equipment is required, and the test can easily be incorporated into a routine diagnostic laboratory. The kit is available in either 12 test or 48 test formats, making it suitable for both small volume users and high throughput laboratories.

To ensure valid results, each sample is co-analyzed with an amplification control, which reliably indicates potential inhibition. It identifies a MRSA-specific fragment not present in methicillin-sensitive S aureus (MSSA) or in coagulase-negative staphylococci. Therefore, no pure culture is required and the material can be directly analyzed from the swab.

Supplied by Hain Lifescience (Nehren, Germany), the GenoQuick MRSA assay is user-friendly. Colored solutions prevent pipetting errors, and the simple detection technique largely reduces pipetting effort. Test results from direct samples are available within only 2.5 hr. The test has received the CE Mark.

One of the most important benefits for labs of all sizes is the reduced need for equipment. Initial costs are therefore considerably lower compared to other MRSA assay systems.



Related Links:
Hain Lifescience

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
X-Ray Generator
Advantage Plus Generators
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.